Published 4 days ago • loading... • Updated 4 days ago

Pharmalittle: We're reading about Trump tariffs on drugs, a delayed Merck vaccine court trial, and more

Summary by STAT

Novo Nordisk accused KBP Biosciences of concealing clinical data ahead of a $1.3 billion licensing agreement for a blood pressure drug

1 Articles

All

Left

Center

Right

Novo Nordisk accused KBP Biosciences of concealing clinical data ahead of a $1.3 billion licensing agreement for a blood pressure drug

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated4 days agoBias Distribution

100% Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States 4 days ago on Wednesday, February 19, 2025.

Sources are mostly out of (0)